Pirfenidone anti-fibrotic effects are partially mediated by the inhibition of MUC1 bioactivation

  1. Ballester, B.
  2. Milara, J.
  3. Cortijo, J.
Revue:
Oncotarget

ISSN: 1949-2553

Année de publication: 2020

Volumen: 11

Número: 15

Pages: 1306-1320

Type: Article

DOI: 10.18632/ONCOTARGET.27526 GOOGLE SCHOLAR lock_openAccès ouvert editor